Cocroft v. Graham

122 F.4th 176
Court of Appeals for the Fifth Circuit·Decided November 22, 2024·No. 24-60086·Published·Cited by 1 cases

Opinion

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

____________ FILED November 22, 2024

No. 24-60086 Lyle W. Cayce ____________ Clerk

Clarence Cocroft; Tru Source Medical Cannabis, L.L.C.,

Plaintiffs—Appellants,

versus

Chris Graham, in his official capacity as the Commissioner of the Mississippi Department of Revenue; Riley Nelson, in his official capacity as the Chief of Enforcement of the Mississippi Alcoholic Beverage Control Bureau;Doctor Daniel P. Edney, in his official capacity as State Health Officer for the State of Mississippi Department of Health,

Defendants—Appellees.

Appeal from the United States District Court for the Northern District of Mississippi USDC No. 3:23-CV-431

Before Smith, Clement, and Higginson, Circuit Judges. Jerry E. Smith, Circuit Judge:

Clarence Cocroft and his medical-marihuana dispensary, Tru Source Medical Cannabis, L.L.C., appeal a judgment of dismissal of their First Amendment challenge to Mississippi’s near-total restriction on the advertising of medical marihuana. The plaintiffs seek declaratory and injunctive relief against several state defendants in their official capacities. The plain-

No. 24-60086

tiffs contend that the First Amendment protects their right to engage in medical-marihuana advertising because Mississippi law permits the underlying commercial transactions.

This case presents an issue of first impression in our Circuit. The parties agree that the speech at issue is commercial and that the Central Hudson test governs our analysis. See Cent. Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n, 447 U.S. 557 (1980). As a threshold matter, commercial speech receives no First Amendment protection if the underlying commercial conduct is illegal. The Controlled Substances Act (“CSA”), 21 U.S.C. § 801 et seq., prohibits activities involving marihuana—including activities involveing medical marihuana—nationwide. And the Supremacy Clause means that the CSA is the law in Mississippi regardless of what state law might say. Marihuana is therefore illegal in Mississippi, and the state faces no constitutional obstacle to restricting commercial speech relating to unlawful transactions . Accordingly, we affirm the judgment of dismissal.

I.

Since 1970, the federal CSA has prohibited the manufacture, distribution , dispensing, and possession of marihuana. Id. §§ 812(Schedule I)(c)(10), 841(a)(1), 844(a). That law additionally criminalizes the advertising of marihuana. Id. §§ 812(Schedule I)(c)(10), 843(c).

In 2022, Mississippi enacted the “Mississippi Medical Cannabis Act,” Miss. Code Ann. § 41-137-1 et seq., which authorizes the sale and use of marihuana for certain medicinal purposes. The Act creates an extensive regulatory and licensing framework, and it charges the Mississippi Department of Health (“MDOH”) and the Mississippi Department of Revenue (“MDOR”) with administering the program. Miss. Code Ann. § 41-137-7. The Act requires both Departments, in that role, to promulgate rules and regulations, including “[r]estrictions on the advertising, signage,

No. 24-60086

and display of medical cannabis[.]” Id. § 41-137-41(1)(d)(x). The Act specifically permits some advertising, though. The Departments’ rules may not prevent appropriate signs on the property of a dispensary , listings in business directories, including phone books, listings in cannabis-related or medical publications, display of cannabis in company logos and other branding activities, display on dispensary websites of pictures of products that the dispensary sells, or the sponsorship of health or not-for-profit charity or advocacy events[.]

Id.

MDOH has exercised its regulatory authority to the full extent permitted under the Act; its rules prohibit medical-marihuana “advertising and marketing in any media, including but not limited to” broadcast, electronic, and print media. 15 Miss. Admin. Code Pt. 22, Subpt. 9, R. 9.1.1. The prohibition also extends to mass text and email communications, displays of medical cannabis products “in windows or public view,” advertisements “that can be viewable or otherwise perceived as a public space,” and solicited or paid reviews, testimonies, or endorsements from patients, caregivers, or practitioners. Id. The MDOH rules do, however, authorize licensed medical cannabis establishments “to participate in [specified] branding activities . . . in order to publicize their businesses.” Id. Pt. 22, Subpt. 9, R. 9.2.1. “Permissible branding activities include:”

1. Establishment of a website and/or social media presence that provides general information on the licensed entity’s contact information, retail dispensing locations, and a list of products available; 2. Listings in business directories (inclusive of phone books, cannabis-related or medical publications); 3. Display of cannabis in company logos and other branding

No. 24-60086

activities; and, 4. Sponsorships of health or not-for-profit charity or advocacy events.

Id. Pt. 22, Subpt. 9, R. 9.2.2. 1 The plaintiffs allege that they are injured by Mississippi’s rules because they cannot advertise “in ways that allow them to effectively reach new customers,” “inform the public about Mississippi’s medical marijuana program ,” and “inform the public about Tru Source’s location, products, and prices.” Were it not for these restrictions, the plaintiffs maintain, they would advertise through print, broadcast, social, and other media. The plaintiffs contend that the First Amendment’s Free Speech Clause protects their right to engage in such advertising because Mississippi law has authorized the underlying commercial transactions.

The district court granted the defendants’ Federal Rule of Civil Procedure 12(b)(6) motion to dismiss for failure to state a claim. Evaluating the case under Central Hudson, the court held that medical-marihuana advertising does not qualify for First Amendment protection because federal law criminalizes the underlying transactions.

II.

“We review de novo a district court’s dismissal under Rule 12(b)(6).”

Vizaline, L.L.C. v. Tracy, 949 F.3d 927, 931 (5th Cir. 2020) (quotation and citation omitted). “We accept all well-pleaded facts as true, construing all reasonable inferences in the light most favorable to the plaintiff. But we do

1 The only form of advertising that MDOH permits that the Act (arguably) does not require it to allow is a dispensary social-media presence for providing general information . Compare Miss. Code Ann. § 41-137-41(1)(d)(x) with 15 Miss. Admin. Code Pt. 22, Subpt. 9, R. 9.2.2.

No. 24-60086

not accept as true conclusory allegations, unwarranted factual inferences, or legal conclusions.” Hernandez v. W. Tex. Treasures Est. Sales, L.L.C., 79 F.4th 464, 469 (5th Cir. 2023) (cleaned up).

“It is well established that the party seeking to uphold a restriction on commercial speech carries the burden of justifying it.” Edenfield v. Fane, 507 U.S. 761, 770 (1993) (cleaned up). Thus, “the State ha[s] the burden to prove all elements of the Central Hudson test.” Byrum v. Landreth, 566 F.3d 442, 446 (5th Cir. 2009).

III.

In Central Hudson, the Court set forth the four-prong test for evaluating the regulation of commercial speech:

At the outset, we must determine whether the expression is protected by the First Amendment. For commercial speech to come within that provision, it at least must concern lawful activity and not be misleading. Next, we ask whether the asserted governmental interest is substantial. If both inquiries yield positive answers, we must determine whether the regulation directly advances the governmental interest asserted, and whether it is not more extensive than is necessary to serve that interest.

447 U.S. at 566.

Free access — add to your briefcase to read the full text and ask questions with AI

Cocroft v. Graham, 122 F.4th 176 (5th Cir. 2024).

122 F.4th 176 (Cocroft v. Graham) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related